Press Releases
BOSTON, Dec. 18, 2019 /PRNewswire/ -- Keeping fit while traveling during the holidays and beyond can be a challenge. To help solve this problem, the International Health, Racquet & Sportsclub Association (I
Read more...NEW YORK, Dec. 18, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We are by far the best branded source in the nation
Read more...18 December 2019
LINDON, Utah, Dec. 18, 2019 /PRNewswire/ -- TheraLight, LLC, an FDA registered manufacturer and distributor of cutting-edge light therapy products, announced that its flagship product, TheraLight 360, has been nominated for an Edison Award, an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation.
Read more...18 December 2019
Supreme Cannabis expands recreational distribution to all ten Canadian provinces; 7ACRES products will now be available in Québec and Newfoundland and Labrador; TORONTO, Dec. 18, 2019 /PRNewswire/ -
Read more...18 December 2019
NEW YORK, Dec. 18, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) and Mylan N.V. (NASDAQ: MYL) today announced that Ian Read and James Kilts will join the Viatris board of directors upon completion of the planned combination of Mylan N.V. and Upjohn Inc., which is expected to occur in mid-2020. The Viatris board
Read more...18 December 2019
ATLANTA, Dec. 18, 2019 /PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, today announced the appointment of Todd Verdoorn, PhD., as Vice President of Research and Development. In this capacity, Dr. Verdoorn will provide leadership and oversight for NTS's development of biopharmaceutical programs focused on s
Read more...BAUDETTE, Minn., Dec. 18, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Bretylium Tosylate Injection USP, 50 mg/mL. Bretylium Tosylate is a class III antiarrhythmic medication approved for the treatment of ventricular fibrillation and life-threatening ventricular arrhythmias such as ventricular tachycardia.
Read more...18 December 2019
DUBLIN, Dec. 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler will present at the ICR Conference at 9:30 AM EST on Monday, January 13, 2020 at the Grande Lakes Orlando Resort in Orlando, Florida. 
Read more...18 December 2019
SAN JUAN CAPISTRANO, Calif., Dec. 18, 2019 /PRNewswire/ -- A landmark two-year follow-up study on the Ellipsys
Read more...18 December 2019
TEL AVIV, Dec. 18, 2019 /PRNewswire/ -- Panaxia Labs Israel Ltd, the largest manufacturer of medical cannabis products in Israel announced positive topline results in its clinical trial evaluating bioavailability and safety of use of a variety of innovative delivery methods of medical cannabis products developed by the Panaxia
Read more...
